Healthcare provider profile · identity verified

Aleida Hera Jimenez, MD

General Practice · MIAMI, FL · NPI 1649421058

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	730	269
Losartan Potassium	Losartan Potassium	550	202
Atorvastatin Calcium	Atorvastatin Calcium	506	199
Amlodipine Besylate	Amlodipine Besylate	409	154
Metformin Hcl	Metformin Hcl	399	142
Levothyroxine Sodium	Levothyroxine Sodium	370	128
Lisinopril	Lisinopril	347	118
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	334	68
Gabapentin	Gabapentin	308	88
Pantoprazole Sodium	Pantoprazole Sodium	258	88
Glipizide	Glipizide	256	82
Metoprolol Succinate	Metoprolol Succinate	184	68
Hydrochlorothiazide	Hydrochlorothiazide	181	66
Trazodone Hcl	Trazodone Hcl	168	37
Tamsulosin Hcl	Tamsulosin Hcl	158	62
Unifine Pentips	Pen Needle, Diabetic	141	25
Famotidine	Famotidine	135	48
Omeprazole	Omeprazole	133	44
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	132	30
Folic Acid	Folic Acid	129	21
Farxiga	Dapagliflozin Propanediol	126	25
Latanoprost	Latanoprost	124	19
Jardiance	Empagliflozin	122	16
Xarelto	Rivaroxaban	120	17
Methylprednisolone	Methylprednisolone	113	95
Pioglitazone Hcl	Pioglitazone Hcl	108	33
Carvedilol	Carvedilol	103	31
Eliquis	Apixaban	101	23
Vitamin D2	Ergocalciferol (Vitamin D2)	101	25
Metoprolol Tartrate	Metoprolol Tartrate	98	37
Albuterol Sulfate Hfa	Albuterol Sulfate	90	29
Alendronate Sodium	Alendronate Sodium	89	34
Nifedipine Er	Nifedipine	87	33
Simvastatin	Simvastatin	87	29
Tradjenta	Linagliptin	86	14
Azithromycin	Azithromycin	83	78
Furosemide	Furosemide	81	34
Temazepam	Temazepam	81	17
Clopidogrel	Clopidogrel Bisulfate	80	34
Montelukast Sodium	Montelukast Sodium	79	27
Sildenafil Citrate	Sildenafil Citrate	79	24
Benzonatate	Benzonatate	69	58
Fenofibrate	Fenofibrate Nanocrystallized	68	38
Escitalopram Oxalate	Escitalopram Oxalate	66	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	65	23
Duloxetine Hcl	Duloxetine Hcl	62	12
Ibuprofen	Ibuprofen	61	44
Meclizine Hcl	Meclizine Hcl	60	32
Baclofen	Baclofen	59	51
Memantine Hcl	Memantine Hcl	54	27
Finasteride	Finasteride	53	24
Sertraline Hcl	Sertraline Hcl	53	20
Valsartan	Valsartan	53	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	14
Donepezil Hcl	Donepezil Hcl	47	22
Atenolol	Atenolol	44	13
Oxybutynin Chloride Er	Oxybutynin Chloride	44	13
Glimepiride	Glimepiride	42	13
Allopurinol	Allopurinol	40	13
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	40	34
Naproxen	Naproxen	40	31
Tadalafil	Tadalafil	39	suppressed
Diclofenac Sodium	Diclofenac Sodium	37	24
Ketoconazole	Ketoconazole	35	18
Hydralazine Hcl	Hydralazine Hcl	34	13
Trueplus Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	34	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	33	12
Insulin Aspart Flexpen	Insulin Aspart	33	suppressed
Lovastatin	Lovastatin	31	13
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	30	suppressed
Entresto	Sacubitril/Valsartan	30	suppressed
Fluticasone Propionate	Fluticasone Propionate	29	23
Spironolactone	Spironolactone	29	11
Oxybutynin Chloride	Oxybutynin Chloride	28	suppressed
Prednisone	Prednisone	28	15
Ammonium Lactate	Ammonium Lactate	26	17
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	23
Irbesartan	Irbesartan	26	suppressed
Acyclovir	Acyclovir	25	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	25	suppressed
Timolol Maleate	Timolol Maleate	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	19
Lactulose	Lactulose	24	15
Lumigan	Bimatoprost	24	suppressed
Ozempic	Semaglutide	23	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Glipizide Er	Glipizide	22	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Methotrexate	Methotrexate Sodium	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Bumetanide	Bumetanide	19	suppressed
Ciclopirox	Ciclopirox	19	11
Janumet Xr	Sitagliptin Phos/Metformin Hcl	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	15
Clonidine Hcl	Clonidine Hcl	18	suppressed
Insulin Aspart	Insulin Aspart	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Linzess	Linaclotide	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	15
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	12
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Ciprofloxacin-Dexamethasone	Ciprofloxacin Hcl/Dexameth	16	16
Lantus	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Rivastigmine	Rivastigmine Tartrate	16	suppressed
Spiriva Respimat	Tiotropium Bromide	16	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Metformin Hcl Er	Metformin Hcl	14	suppressed
Novolog	Insulin Aspart	14	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Meloxicam	Meloxicam	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Procto-Med Hc	Hydrocortisone	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	12
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Rocklatan	Netarsudil Mesylat/Latanoprost	12	suppressed
Trueplus Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	12	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Pentoxifylline	Pentoxifylline	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error